VA House · HB 795

Health insurance; requirements for certain opioid antagonists.

In plain English (AI summary)

This legislation aims to increase access to life-saving overdose reversal medication across Virginia. It mandates that health insurance carriers providing coverage for prescription drugs must include at least one opioid antagonist—such as Naloxone—on their formulary. The bill also prohibits these carriers from imposing excessive cost-sharing requirements, such as high deductibles or copays, for these emergency medications. By streamlining insurance coverage and lowering out-of-pocket costs, the policy seeks to ensure that individuals and families can affordably obtain these critical tools to respond to opioid-related emergencies. For Arlington residents, this means that those covered by state-regulated health insurance plans will likely see improved accessibility and reduced financial barriers when obtaining medication necessary to prevent fatal overdoses in the community.

View original bill

Roll-call votes

Roll call
Mar 12, 2026 · VA House · pass
96 – 0 · 3 other
Full roll call
Passage
Mar 11, 2026 · VA Senate · pass
39 – 0 · 1 other
Full roll call
Passage
Mar 11, 2026 · VA Senate · pass
40 – 0
Full roll call
Reconsider
Mar 11, 2026 · VA Senate · pass
40 – 0
Full roll call
Constitutional reading dispensed (on 2nd reading)
Mar 10, 2026 · VA Senate · pass
37 – 0 · 3 other
Full roll call
Reported from Finance and Appropriations
Mar 9, 2026 · VA Senate · pass
14 – 0 · 1 other
Arlington delegation
Full roll call
Roll call
Feb 13, 2026 · VA House · pass
96 – 0 · 4 other
Full roll call
Reported from Labor and Commerce with substitute
Feb 5, 2026 · VA House · pass
22 – 0
Arlington delegation
Full roll call